{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:06:26Z","timestamp":1790186786556,"version":"4.1.0"},"reference-count":163,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1097\/00000441-200108000-00007","type":"journal-article","created":{"date-parts":[[2003,11,10]],"date-time":"2003-11-10T11:15:48Z","timestamp":1068462948000},"page":"88-102","source":"Crossref","is-referenced-by-count":21,"title":["Factor V Leiden: A Clinical Review"],"prefix":"10.1016","volume":"322","author":[{"given":"Norman M.","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biff F.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/00000441-200108000-00007_bb0005","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archinte.1991.00400050081016","article-title":"A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism","volume":"151","author":"Anderson","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1097\/00000441-200108000-00007_bb0010","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1073\/pnas.90.3.1004","article-title":"Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C","volume":"90","author":"Dahlback","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1097\/00000441-200108000-00007_bb0015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-0037-1615780","article-title":"Biochemistry and physiology of blood coagulation","volume":"82","author":"Mann","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1432-1033.1997.00012.x","article-title":"Cleavage requirements for activation of factor V by factor Xa","volume":"247","author":"Thorelli","year":"1997","journal-title":"Eur J Biochem"},{"key":"10.1097\/00000441-200108000-00007_bb0025","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1161\/01.ATV.19.12.2841","article-title":"Procoagulant expression in platelet and defects leading to clinical disorders","volume":"19","author":"Solum","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1097\/00000441-200108000-00007_bb0030","doi-asserted-by":"crossref","first-page":"31869","DOI":"10.1016\/S0021-9258(18)31776-9","article-title":"The mechanism of inactivation of human factor V and human factor Va by activated protein C","volume":"269","author":"Kalafatis","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1097\/00000441-200108000-00007_bb0035","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-2007-994931","article-title":"Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation","volume":"25","author":"Dahlback","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.1097\/00000441-200108000-00007_bb0040","doi-asserted-by":"crossref","first-page":"21158","DOI":"10.1074\/jbc.270.36.21158","article-title":"Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor Va R506Q by activated protein C","volume":"270","author":"Nicolaes","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1097\/00000441-200108000-00007_bb0045","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1182\/blood.V85.12.3405.bloodjournal85123405","article-title":"Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-Factor V","volume":"85","author":"Heeb","year":"1995","journal-title":"Blood"},{"key":"10.1097\/00000441-200108000-00007_bb0050","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0037-1614462","article-title":"The prevalence of factor V Arg306\u2013>Thr (factor V Cambridge) and factor V Arg306\u2013>Gly mutations in different human populations [letter]","volume":"81","author":"Franco","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0055","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1182\/blood.V92.7.2599","article-title":"Clinical significance of Arg306 mutations of factor V gene [letter]","volume":"92","author":"Liang","year":"1998","journal-title":"Blood"},{"key":"10.1097\/00000441-200108000-00007_bb0060","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1182\/blood.V91.4.1135","article-title":"A novel mutation of Arg306 of factor V gene in Hong Kong Chinese","volume":"91","author":"Chan","year":"1998","journal-title":"Blood"},{"key":"10.1097\/00000441-200108000-00007_bb0065","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1046\/j.1365-2141.1996.349885.x","article-title":"Absence of mutations at the activated protein C cleavage sites of factor VIII in 125 patients with venous thrombosis","volume":"92","author":"Roelse","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1097\/00000441-200108000-00007_bb0070","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1046\/j.1365-2362.1997.1180660.x","article-title":"Search for mutations in the genes for coagulation factors V and VIII with a possible predisposition to activated protein C resistance","volume":"27","author":"Bokarewa","year":"1997","journal-title":"Eur J Clin Invest"},{"key":"10.1097\/00000441-200108000-00007_bb0075","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1055\/s-0037-1614944","article-title":"Mutation in either Arg335 or Arg562 in factor VIII is insufficient for complete resistance to activated protein C (APC)-mediated inactivation: implications for the APC resistance test","volume":"79","author":"Amano","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0080","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1055\/s-0038-1653855","article-title":"Diagnosis of APC resistance in patients on oral anticoagulant therapy","volume":"73","author":"Tosetto","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0085","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1055\/s-0038-1653856","article-title":"Evaluation of APC resistance in the plasma of patients with Q506 mutation of factor V (factor V Leiden) and treated by oral anticoagulants","volume":"73","author":"Cadroy","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0090","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0140-6736(94)90494-4","article-title":"Modified APC resistance assay for patients on oral anticoagulants [letter]","volume":"344","author":"Trossaert","year":"1994","journal-title":"Lancet"},{"key":"10.1097\/00000441-200108000-00007_bb0095","first-page":"23","article-title":"Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT-than APTT-based assays","volume":"56","author":"Favaloro","year":"1999","journal-title":"Br J Biomed Sci"},{"key":"10.1097\/00000441-200108000-00007_bb0100","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1055\/s-0038-1655984","article-title":"Screening for the FV: Q506 mutation - evaluation of thirteen plasma-based methods for their diagnostic efficacy in comparison with DNA analysis","volume":"77","author":"Tripodi","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0105","first-page":"290","article-title":"A highly specific functional test for factor V Leiden: a modified tissue factor assay for activated protein C resistance","volume":"27","author":"Arkel","year":"1997","journal-title":"Haemostasis"},{"key":"10.1097\/00000441-200108000-00007_bb0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1055\/s-2007-996019","article-title":"Laboratory diagnosis of hereditary thrombophilia","volume":"24","author":"Michiels","year":"1998","journal-title":"Semin Thromb Hemost"},{"key":"10.1097\/00000441-200108000-00007_bb0115","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/jcp.52.10.766","article-title":"Rapid detection of the factor V Leiden (1691G>A) and haemochromatosis (845G>A) mutation by fluorescence resonance energy transfer and real time PCR","volume":"52","author":"Neoh","year":"1999","journal-title":"J Clin Path"},{"key":"10.1097\/00000441-200108000-00007_bb0120","doi-asserted-by":"crossref","first-page":"643","DOI":"10.7326\/0003-4819-130-8-199904200-00004","article-title":"Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism","volume":"130","author":"Rodeghiero","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1097\/00000441-200108000-00007_bb0125","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1378\/chest.111.6.1603","article-title":"Factor V Leiden prevalence in venous thromboembolism patients","volume":"111","author":"Leroyer","year":"1997","journal-title":"Chest"},{"key":"10.1097\/00000441-200108000-00007_bb0130","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1055\/s-2007-1024412","article-title":"Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population","volume":"124","author":"Ehrenforth","year":"1999","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1097\/00000441-200108000-00007_bb0135","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00001721-199711000-00001","article-title":"Factor V Leiden in Greek thrombophilic patients: relationship with activated protein C resistance test and levels of thrombin-antithrombin complex and prothrombin fragment 1+2","volume":"8","author":"Lambropoulos","year":"1997","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1097\/00000441-200108000-00007_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0049-3848(98)00136-4","article-title":"The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels","volume":"93","author":"Cattaneo","year":"1999","journal-title":"Thromb Res"},{"key":"10.1097\/00000441-200108000-00007_bb0145","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1399-0004.1997.tb02548.x","article-title":"Factor V Leiden (R506Q) and risk of venous thromboembolism: a case- control study based on the Spanish population","volume":"52","author":"Garcia-Gala","year":"1997","journal-title":"Clin Genet"},{"key":"10.1097\/00000441-200108000-00007_bb0150","first-page":"378","article-title":"Incidence and clinical manifestations of activated protein C resistance and factor V Leiden in young patients with venous thromboembolic disease in Spain [letter]","volume":"83","author":"Olave","year":"1998","journal-title":"Haematologica"},{"key":"10.1097\/00000441-200108000-00007_bb0155","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2796.1997.124140000.x","article-title":"The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis","volume":"241","author":"Svensson","year":"1997","journal-title":"J Intern Med"},{"key":"10.1097\/00000441-200108000-00007_bb0160","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1055\/s-0038-1656143","article-title":"Relative risk of pulmonary embolism and deep venous thrombosis in association with the factor V Leiden mutation in a United Kingdom population [letter]","volume":"77","author":"Baglin","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0165","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1182\/blood.V93.4.1271","article-title":"A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis","volume":"93","author":"de Visser","year":"1999","journal-title":"Blood"},{"key":"10.1097\/00000441-200108000-00007_bb0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/joim.1997.242.s740.9","article-title":"Familial thrombophilia: genetic risk factors and management","volume":"740","author":"Makris","year":"1997","journal-title":"J Intern Med Suppl"},{"key":"10.1097\/00000441-200108000-00007_bb0175","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0049-3848(97)00275-2","article-title":"Prevalence of activated protein C resistance in the Chinese population","volume":"88","author":"Ho","year":"1997","journal-title":"Thromb Res"},{"key":"10.1097\/00000441-200108000-00007_bb0180","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3346\/jkms.1998.13.6.587","article-title":"Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis","volume":"13","author":"Kim","year":"1998","journal-title":"J Korean Med Sci"},{"key":"10.1097\/00000441-200108000-00007_bb0185","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000203548","article-title":"Resistance to activated protein C and Arg 506 Gln factor V mutation are uncommon in eastern Asian populations","volume":"98","author":"Kodaira","year":"1997","journal-title":"Acta Haematol"},{"key":"10.1097\/00000441-200108000-00007_bb0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0925-5710(96)00527-0","article-title":"Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Japanese patients with various forms of thrombosis, and normal individuals","volume":"65","author":"Zama","year":"1996","journal-title":"Int J Hematol"},{"key":"10.1097\/00000441-200108000-00007_bb0195","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/(SICI)1096-8628(19971219)73:3<334::AID-AJMG20>3.0.CO;2-J","article-title":"Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations","volume":"73","author":"Gregg","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1097\/00000441-200108000-00007_bb0200","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/oxfordjournals.aje.a009363","article-title":"Relation of three genetic traits to venous thrombosis in an African-American population","volume":"147","author":"Dilley","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1097\/00000441-200108000-00007_bb0205","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/(SICI)1098-2272(1997)14:4<403::AID-GEPI5>3.0.CO;2-3","article-title":"Prevalence of factor V Leiden mutation in various populations","volume":"14","author":"Herrmann","year":"1997","journal-title":"Genet Epidemiol"},{"key":"10.1097\/00000441-200108000-00007_bb0210","first-page":"875","article-title":"Prevalence of factor V Leiden in the Chinese population","volume":"62","author":"Ho","year":"1999","journal-title":"Zhonghua Yi Xue Za Zhi Taipei"},{"key":"10.1097\/00000441-200108000-00007_bb0215","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s004390050184","article-title":"The G1691A mutation of the coagulation factor V gene (factor V Leiden) is rare in Chinese: an analysis of 618 individuals","volume":"98","author":"Ko","year":"1996","journal-title":"Hum Genet"},{"key":"10.1097\/00000441-200108000-00007_bb0220","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01745044","article-title":"Arg506Gln mutation of the coagulation factor V gene not detected in Japanese pulmonary thromboembolism","volume":"13","author":"Seki","year":"1998","journal-title":"Heart Vessels"},{"key":"10.1097\/00000441-200108000-00007_bb0225","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.1997.03540400055031","article-title":"Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening","volume":"277","author":"Ridker","year":"1997","journal-title":"JAMA"},{"key":"10.1097\/00000441-200108000-00007_bb0230","doi-asserted-by":"crossref","first-page":"737","DOI":"10.7326\/0003-4819-128-9-199805010-00006","article-title":"Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California","volume":"128","author":"White","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1097\/00000441-200108000-00007_bb0235","doi-asserted-by":"crossref","first-page":"895","DOI":"10.7326\/0003-4819-127-10-199711150-00007","article-title":"Leiden mutation and the risks for thromboembolic disease: a clinical perspective","volume":"127","author":"Price","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1097\/00000441-200108000-00007_bb0240","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1055\/s-0037-1614442","article-title":"Incidence of venous thromboembolism in families with inherited thrombophilias","volume":"81","author":"Simoni","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0245","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1182\/blood.V92.7.2353","article-title":"Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families","volume":"92","author":"Martinelli","year":"1998","journal-title":"Blood"},{"key":"10.1097\/00000441-200108000-00007_bb0250","doi-asserted-by":"crossref","first-page":"561S","DOI":"10.1378\/chest.114.5_Supplement.561S","article-title":"Antithrombotic therapy for venous thromboembolic disease","volume":"114","author":"Hyers","year":"1998","journal-title":"Chest"},{"key":"10.1097\/00000441-200108000-00007_bb0255","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1056\/NEJM199506223322501","article-title":"A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group","volume":"332","author":"Schulman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200108000-00007_bb0260","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199702063360601","article-title":"The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group","volume":"336","author":"Schulman","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200108000-00007_bb0265","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199903253401201","article-title":"A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism [published erratum appears in N Engl J Med 1999;341:298","volume":"340","author":"Kearon","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200108000-00007_bb0270","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1161\/01.CIR.92.10.2800","article-title":"Factor V Leiden and risks of recurrent idiopathic venous thromboembolism","volume":"92","author":"Ridker","year":"1995","journal-title":"Circulation"},{"key":"10.1097\/00000441-200108000-00007_bb0275","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1055\/s-0038-1656023","article-title":"The risk of recurrent venous thromboembolism in patients with and without factor V Leiden","volume":"77","author":"Eichinger","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0280","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1055\/s-0037-1614554","article-title":"The risk of recurrent venous thromboembolism in carriers and non- carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group Duration of Anticoagulation","volume":"81","author":"Lindmarker","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0285","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1055\/s-0037-1614882","article-title":"Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism","volume":"82","author":"Margaglione","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0290","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJM199702063360602","article-title":"The risk of recurrent venous thromboembolism in patients with an Arg506- ->Gln mutation in the gene for factor V (factor V Leiden)","volume":"336","author":"Simioni","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200108000-00007_bb0295","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199909093411104","article-title":"The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation","volume":"641","author":"de Stefano","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200108000-00007_bb0300","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1055\/s-0038-1656022","article-title":"Clinical features in 36 patients homozygous for the ARG 506\u2013>GLN factor V mutation","volume":"77","author":"Emmerich","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0305","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archinte.159.5.445","article-title":"Predictors of survival after deep vein thrombosis and pulmonary embolism","volume":"159","author":"Heit","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1097\/00000441-200108000-00007_bb0310","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1055\/s-0037-1615372","article-title":"Factor V Leiden and venous thrombosis in Danish centenarians","volume":"80","author":"Kristensen","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0315","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0140-6736(96)90181-6","article-title":"Mutant factor V (Arg506Gln)in healthy centenarians [letter]","volume":"347","author":"Mari","year":"1996","journal-title":"Lancet"},{"key":"10.1097\/00000441-200108000-00007_bb0320","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1055\/s-0038-1665411","article-title":"Factor V Leiden and thermolabile methylenetetrahydrofolate reductase in extreme old age","volume":"78","author":"Rees","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0325","first-page":"607","article-title":"The risk of mortality and the factor V Leiden mutation in a population-based cohort","volume":"80","author":"Heijmans","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0330","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1182\/blood.V89.6.1963","article-title":"Mortality and causes of death in families with the factor V Leiden mutation (resistance to activated protein C)","volume":"89","author":"Hille","year":"1997","journal-title":"Blood"},{"key":"10.1097\/00000441-200108000-00007_bb0335","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(86)90111-X","article-title":"Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study","volume":"2","author":"Meade","year":"1986","journal-title":"Lancet"},{"key":"10.1097\/00000441-200108000-00007_bb0340","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1055\/s-0037-1615353","article-title":"Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction\u2013the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction","volume":"80","author":"Scarabin","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0345","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1056\/NEJM199504063321403","article-title":"Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men","volume":"332","author":"Ridker","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200108000-00007_bb0350","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/blood.V93.7.2186","article-title":"Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males","volume":"93","author":"Inbal","year":"1999","journal-title":"Blood"},{"key":"10.1097\/00000441-200108000-00007_bb0355","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/01.CIR.97.11.1037","article-title":"Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A","volume":"97","author":"Doggen","year":"1998","journal-title":"Circulation"},{"key":"10.1097\/00000441-200108000-00007_bb0360","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/01.ATV.19.4.1020","article-title":"Coagulation factors II, V, VII, and X, prothrombin gene 20210G\u2013>A transition; and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction","volume":"19","author":"Redondo","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1097\/00000441-200108000-00007_bb0365","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1182\/blood.V94.1.46.413a27_46_51","article-title":"Prothrombotic genetic risk factors in young survivors of myocardial infarction","volume":"94","author":"Ardissino","year":"1999","journal-title":"Blood"},{"key":"10.1097\/00000441-200108000-00007_bb0370","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1055\/s-0037-1613927","article-title":"Prevalence of factor V Leiden in patients with myocardial infarction and normal coronary angiography","volume":"83","author":"Mansourati","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0375","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0735-1097(00)00772-5","article-title":"Prevalence of factor V Leiden and prothrombin variant G20210A in patients age <50years with no significant stenoses at angiography three to four weeks after myocardial infarction","volume":"36","author":"Van de Water","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/00000441-200108000-00007_bb0380","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1018652429633","article-title":"Incidence of factor V Leiden in patients with acute myocardial infarction","volume":"9","author":"Gowda","year":"2000","journal-title":"J Thromb Thrombolysis"},{"key":"10.1097\/00000441-200108000-00007_bb0385","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood.V89.8.2817","article-title":"Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women","volume":"89","author":"Rosendaal","year":"1997","journal-title":"Blood"},{"key":"10.1097\/00000441-200108000-00007_bb0390","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1182\/blood.V93.4.1432","article-title":"Factor V Leiden is not a risk factor for myocardial infarction among young women [letter]","volume":"93","author":"Amowitz","year":"1999","journal-title":"Blood"},{"key":"10.1097\/00000441-200108000-00007_bb0395","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1055\/s-0037-1615092","article-title":"Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health Study","volume":"79","author":"Cushman","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0400","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0037-1614444","article-title":"The factor II G20210A and factor V G1691A gene transitions and coronary heart disease","volume":"81","author":"Gardemann","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0405","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF00198904","article-title":"Evidence against heterozygous coagulation factor V 1691 G\u2013>A mutation with resistance to activated protein C being a risk factor for coronary artery disease and myocardial infarction","volume":"73","author":"Prohaska","year":"1995","journal-title":"J Mol Med"},{"key":"10.1097\/00000441-200108000-00007_bb0410","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.ATV.17.2.246","article-title":"Polymorphisms of factor V, factor VII, and fibrinogen genes. Relevance to severity of coronary artery disease","volume":"17","author":"Wang","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1097\/00000441-200108000-00007_bb0415","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0049-3848(98)00076-0","article-title":"Role of factor V Leiden mutation in patients with angiographically demonstrated coronary artery disease","volume":"91","author":"Dunn","year":"1998","journal-title":"Thromb Res"},{"key":"10.1097\/00000441-200108000-00007_bb0420","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.ATV.19.7.1776","article-title":"The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly. Results from the Cardiovascular Health Study","volume":"19","author":"Tracy","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1097\/00000441-200108000-00007_bb0425","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.CIR.100.7.736","article-title":"Prospective study of markers of hemostatic function with risk of ischemic stroke","volume":"100","author":"Folsom","year":"1999","journal-title":"Circulation"},{"key":"10.1097\/00000441-200108000-00007_bb0430","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1161\/01.STR.31.12.3067","article-title":"Diagnostic testing for coagulopathies in patients with ischemic stroke","volume":"31","author":"Bushnell","year":"2000","journal-title":"Stroke"},{"key":"10.1097\/00000441-200108000-00007_bb0435","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1161\/01.STR.27.7.1163","article-title":"Activated protein C resistance in ischemic stroke not due to factor V arginine506\u2013>glutamine mutation","volume":"27","author":"Fisher","year":"1996","journal-title":"Stroke"},{"key":"10.1097\/00000441-200108000-00007_bb0440","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.STR.27.1.44","article-title":"Ischemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated protein C","volume":"27","author":"Press","year":"1996","journal-title":"Stroke"},{"key":"10.1097\/00000441-200108000-00007_bb0445","first-page":"105","article-title":"Factor-V (Arg506 \u2013> Gln) mutation in ischemic cerebrovascular disease","volume":"27","author":"Iniesta","year":"1997","journal-title":"Haemostasis"},{"key":"10.1097\/00000441-200108000-00007_bb0450","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/01.ATV.15.6.783","article-title":"Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke","volume":"15","author":"Catto","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1097\/00000441-200108000-00007_bb0455","first-page":"9","article-title":"Low prevalence of the factor V Leiden among patients with ischemic stroke","volume":"27","author":"Sanchez","year":"1997","journal-title":"Haemostasis"},{"key":"10.1097\/00000441-200108000-00007_bb0460","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1182\/blood.V91.10.3562","article-title":"Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients","volume":"91","author":"De","year":"1998","journal-title":"Blood"},{"key":"10.1097\/00000441-200108000-00007_bb0465","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7326\/0003-4819-125-4-199608150-00002","article-title":"Reduced response to activated protein C is associated with increased risk for cerebrovascular disease","volume":"125","author":"van der Bom","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1097\/00000441-200108000-00007_bb0470","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0049-3848(98)00154-6","article-title":"C677T MTHFR mutation and factor V Leiden mutation in patients with TIA\/minor stroke: a case-control study","volume":"93","author":"Lalouschek","year":"1999","journal-title":"Thromb Res"},{"key":"10.1097\/00000441-200108000-00007_bb0475","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1055\/s-0038-1653820","article-title":"Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction","volume":"73","author":"Kontula","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0480","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1161\/01.ATV.19.7.1751","article-title":"Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden","volume":"19","author":"Margaglione","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1097\/00000441-200108000-00007_bb0485","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1055\/s-0037-1614555","article-title":"Factor V Leiden, prothrombin 20210G\u2013>A and the MTHFR C677T mutations in childhood stroke","volume":"81","author":"McColl","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0490","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1055\/s-0037-1615355","article-title":"Factor V Leiden and prothrombin gene G 20210A variant in children with ischemic stroke","volume":"80","author":"Zenz","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0495","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJM199806183382502","article-title":"High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives","volume":"338","author":"Martinelli","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200108000-00007_bb0500","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1161\/01.STR.29.12.2507","article-title":"Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients","volume":"29","author":"Ludemann","year":"1998","journal-title":"Stroke"},{"key":"10.1097\/00000441-200108000-00007_bb0505","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.STR.27.10.1724","article-title":"Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis","volume":"27","author":"Deschiens","year":"1996","journal-title":"Stroke"},{"key":"10.1097\/00000441-200108000-00007_bb0510","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bmj.316.7131.589","article-title":"Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group [published erratum appears in BMJ 1998;316:822]","volume":"316","author":"de Bruijn","year":"1998","journal-title":"BMJ"},{"key":"10.1097\/00000441-200108000-00007_bb0515","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-0037-1614421","article-title":"A longitudinal study of the relationships between haemostatic, lipid, and oestradiol changes during normal human pregnancy","volume":"81","author":"Sattar","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0520","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1055\/s-0037-1615035","article-title":"Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy","volume":"79","author":"Clark","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0525","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000299596","article-title":"Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I Normal condition","volume":"12","author":"Hellgren","year":"1981","journal-title":"Gynecol Obstet Invest"},{"key":"10.1097\/00000441-200108000-00007_bb0530","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1055\/s-0037-1614518","article-title":"APC Resistance and other Hemostatic Variables during Pregnancy and Puerperium","volume":"81","author":"Kjellberg","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0535","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0002-9378(97)70456-3","article-title":"Changes in activated protein C resistance during normal pregnancy","volume":"177","author":"Walker","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1097\/00000441-200108000-00007_bb0540","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1365-2141.1995.00271.x","article-title":"Activated protein C sensitivity ratio in pregnant women at delivery","volume":"92","author":"Mathonnet","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1097\/00000441-200108000-00007_bb0545","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2141.1995.tb05610.x","article-title":"Development of resistance to activated protein C during pregnancy","volume":"90","author":"Cumming","year":"1995","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"10.1097\/00000441-200108000-00007_bb0550","first-page":"49","article-title":"Inherited thrombophilia and pregnancy: the obstetric perspective","volume":"24","author":"Bonnar","year":"1998","journal-title":"Semin Thromb Hemost"},{"key":"10.1097\/00000441-200108000-00007_bb0555","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM200002103420602","article-title":"Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium","volume":"342","author":"Gerhardt","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200108000-00007_bb0560","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1365-2141.1996.d01-1496.x","article-title":"Arg506-Gln mutation in factor V and risk of thrombosis during pregnancy","volume":"92","author":"Bokarewa","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1097\/00000441-200108000-00007_bb0565","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1055\/s-0038-1657712","article-title":"Risk factors for pregnancy associated venous thromboembolism","volume":"78","author":"McColl","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0570","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0002-9378(97)70617-3","article-title":"Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy","volume":"176","author":"Hallak","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1097\/00000441-200108000-00007_bb0575","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0002-9378(98)70155-3","article-title":"Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations","volume":"179","author":"Grandone","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1097\/00000441-200108000-00007_bb0580","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0015-0282(99)00133-8","article-title":"Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss","volume":"71","author":"Kutteh","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1097\/00000441-200108000-00007_bb1595","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1055\/s-0037-1614519","article-title":"Activated protein C resistance (FV: Q506) and pregnancy","volume":"81","author":"Lindquist","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0585","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0165-0378(97)00039-9","article-title":"The factor V Leiden mutation is not a common cause of recurrent miscarriage","volume":"34","author":"Dizon-Townson","year":"1997","journal-title":"J Reprod Immunol"},{"key":"10.1097\/00000441-200108000-00007_bb0590","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/humrep\/12.5.1094","article-title":"First-trimester repeated abortion is not associated with activated protein C resistance","volume":"12","author":"Balasch","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1097\/00000441-200108000-00007_bb0595","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/humrep\/14.6.1624","article-title":"A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure","volume":"14","author":"Tal","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1097\/00000441-200108000-00007_bb0600","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-0037-1614620","article-title":"Thrombophilic polymorphisms are common in women with fetal loss without apparent cause","volume":"82","author":"Brenner","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0605","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00007","article-title":"Factor V Leiden mutation as a risk factor for recurrent pregnancy loss","volume":"128","author":"Ridker","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1097\/00000441-200108000-00007_bb0610","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1055\/s-0038-1656060","article-title":"Factor V Leiden is associated with repeated and recurrent unexplained fetal losses","volume":"77","author":"Grandone","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0615","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1055\/s-0037-1614367","article-title":"The risk of fetal loss in family members of probands with factor V Leiden mutation","volume":"82","author":"Tormene","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0620","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJM200010053431405","article-title":"Mutations in coagulation factors in women with unexplained late fetal loss","volume":"343","author":"Martinelli","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200108000-00007_bb0625","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-0037-1614594","article-title":"Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombophilic antecedent","volume":"81","author":"Gris","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0630","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(96)04125-6","article-title":"Increased fetal loss in women with heritable thrombophilia","volume":"348","author":"Preston","year":"1996","journal-title":"Lancet"},{"key":"10.1097\/00000441-200108000-00007_bb0635","doi-asserted-by":"crossref","first-page":"736","DOI":"10.7326\/0003-4819-130-9-199905040-00013","article-title":"Increased risk for fetal loss in carriers of the factor V Leiden mutation","volume":"130","author":"Meinardi","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1097\/00000441-200108000-00007_bb0640","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/01.ATV.20.1.266","article-title":"Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy","volume":"20","author":"Murphy","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1097\/00000441-200108000-00007_bb0645","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM199607253350407","article-title":"Treatment of hypertension in pregnant women","volume":"335","author":"Sibai","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200108000-00007_bb0650","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1471-0528.1994.tb13147.x","article-title":"Hamoestatic, fibrionolytic, and endothelial variables in normal pregnancies and pre-eclampsia","volume":"101","author":"Halligan","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1097\/00000441-200108000-00007_bb0655","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0002-9378(89)90096-3","article-title":"Enhanced thrombin generation in normal and hypertensive pregnancy","volume":"160","author":"de Boer","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1097\/00000441-200108000-00007_bb0660","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/0002-9378(95)91333-5","article-title":"Placental pathologic features of preterm preeclampsia","volume":"173","author":"Salafia","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1097\/00000441-200108000-00007_bb0665","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1055\/s-2007-994955","article-title":"The factor V Leiden mutation is not a common cause of pregnancy-induced hypertension in Japan","volume":"25","author":"Kobashi","year":"1999","journal-title":"Semin Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0670","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9378(97)70515-5","article-title":"Preeclampsia is associated with a reduced response to activated protein C","volume":"176","author":"Lindoff","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1097\/00000441-200108000-00007_bb0675","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0037-1614475","article-title":"Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria","volume":"81","author":"Grandone","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0680","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0002-9378(96)80022-6","article-title":"The factor V Leiden mutation may predispose women to severe preeclampsia","volume":"175","author":"Dizon-Townson","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1097\/00000441-200108000-00007_bb0685","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0002-9378(99)70335-2","article-title":"Preeclampsia and genetic risk factors for thrombosis: a case-control study","volume":"181","author":"de groot","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1097\/00000441-200108000-00007_bb0690","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0002-9378(99)70608-3","article-title":"High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia","volume":"180","author":"van Pampus","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1097\/00000441-200108000-00007_bb0695","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1399-0004.1998.tb02599.x","article-title":"Detection of factor V Leiden mutation in severe pre-eclamptic Hungarian women","volume":"53","author":"Nagy","year":"1998","journal-title":"Clin Genet"},{"key":"10.1097\/00000441-200108000-00007_bb0700","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/01.HYP.33.6.1338","article-title":"Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort","volume":"33","author":"O\u2019Shaughnessy","year":"1999","journal-title":"Hypertension"},{"key":"10.1097\/00000441-200108000-00007_bb0705","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1093\/humrep\/14.12.3112","article-title":"Activated protein C resistance shows an association with pregnancy-induced hypertension","volume":"14","author":"Horstkamp","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1097\/00000441-200108000-00007_bb0710","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(61)91061-3","article-title":"Pulmonary embolism","volume":"2","author":"Jordan","year":"1961","journal-title":"Lancet"},{"key":"10.1097\/00000441-200108000-00007_bb0715","first-page":"1101","article-title":"Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content","volume":"1","author":"Bottiger","year":"1980","journal-title":"Lancet"},{"key":"10.1097\/00000441-200108000-00007_bb0720","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-0038-1657547","article-title":"Oral contraceptives and thrombotic disease: risk of venous thromboembolism","volume":"78","author":"Helmerhorst","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0725","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1001\/archinte.1997.00440350022002","article-title":"A reevaluation of the risk for venous thrombosis with the use of oral contraceptives and hormone replacement therapy","volume":"157","author":"Douketis","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1097\/00000441-200108000-00007_bb0730","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00006254-198507000-00003","article-title":"Effects of oral contraceptives on blood coagulation","volume":"40","author":"Beller","year":"1985","journal-title":"A review Ob Gyn Surv"},{"key":"10.1097\/00000441-200108000-00007_bb0735","first-page":"203","article-title":"Effect of oral contraceptives on haemostasis variables","volume":"57","author":"Kluft","year":"1997","journal-title":"Contraception"},{"key":"10.1097\/00000441-200108000-00007_bb0740","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1055\/s-0038-1653788","article-title":"Sensitivity to activated protein C; influence of oral contraceptives and sex","volume":"73","author":"Henkens","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0745","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(99)06092-4","article-title":"Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study","volume":"354","author":"Rosing","year":"1999","journal-title":"Lancet"},{"key":"10.1097\/00000441-200108000-00007_bb0750","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and non-fatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1097\/00000441-200108000-00007_bb0755","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","article-title":"Third-generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study","volume":"312","author":"Spitzer","year":"1996","journal-title":"BMJ"},{"key":"10.1097\/00000441-200108000-00007_bb0760","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"key":"10.1097\/00000441-200108000-00007_bb0765","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1097\/00000441-200108000-00007_bb0770","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.ATV.19.3.700","article-title":"Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis","volume":"19","author":"Martinelli","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1097\/00000441-200108000-00007_bb0775","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0015-0282(99)00318-0","article-title":"Screening for factor V Leiden mutation before prescribing combination oral contraceptives","volume":"72","author":"Creinin","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1097\/00000441-200108000-00007_bb0780","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-127-11-199712010-00001","article-title":"Cost-effectiveness of extending screening mammography to include women 40 to 49years of age","volume":"127","author":"Salzmann","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1097\/00000441-200108000-00007_bb0785","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/bmj.316.7125.95","article-title":"Decision analysis model of prolonged oral anticoagulant treatment in factor V Leiden carriers with first episode of deep vein thrombosis","volume":"316","author":"Sarasin","year":"1998","journal-title":"BMJ"},{"key":"10.1097\/00000441-200108000-00007_bb0790","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1055\/s-0037-1614110","article-title":"Extended anticoagulation for prevention of recurrent venous thromboembolism in carriers of factor V Leiden\u2013cost-effectiveness analysis","volume":"84","author":"Marchetti","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0795","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0301-2115(98)00083-9","article-title":"Low-molecular weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study","volume":"80","author":"Riyazi","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1097\/00000441-200108000-00007_bb0800","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low-molecular-weight heparin in pregnancy: a systematic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1097\/00000441-200108000-00007_bb0805","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1471-0528.2000.tb13240.x","article-title":"The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutation","volume":"107","author":"Younis","year":"2000","journal-title":"Br J Obs Gyn"},{"key":"10.1097\/00000441-200108000-00007_bb0810","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0037-1613894","article-title":"Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin","volume":"83","author":"Brenner","year":"2000","journal-title":"Thromb Haemost"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915346140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915346140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T18:47:46Z","timestamp":1623523666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915346140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":163,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["S0002962915346140"],"URL":"https:\/\/doi.org\/10.1097\/00000441-200108000-00007","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}